Replies to post #206160 on Biotech Values

[GrthzGd]

So, maybe an improvement upon Humira....

[DewDiligence]

MNTA’s CEO says M230 is the most exciting compound in the company’s pipeline; this PR (from Nov 2016) explains what it is:

http://ir.momentapharma.com/releasedetail.cfm?ReleaseID=999935

(The post this message replies to contained an expired link from Yahoo.)